CTIS
CTIS is a Rockville, Maryland-based Women-Owned Small Business providing health IT services to federal healthcare agencies and academic medical centers, and in April 2026 launched Trial SafetyXchange, a SaaS platform that automates FDA E2B(R3) adverse event reporting compliance for pharma, biotech, and CRO customers.
- Company typePrivate
- Founded1993
- HeadquartersRockville, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What CTIS does
CTIS, Inc. is a privately held, Women-Owned Small Business headquartered in Rockville, Maryland, with over 30 years of experience in health IT and clinical research informatics. The company provides end-to-end Health IT services including Data Services, Health Information Solutions, IT Modernization, AI/ML Enablement, IT Infrastructure and Security, and DevSecOps, primarily to federal healthcare and research agencies (NIH, FDA, VA, CMS, FDIC) and academic medical institutions (Georgetown University, Johns Hopkins, Moffitt Cancer Center). CTIS holds ISO 9001, ISO 27001, ISO 20000-1, and CMMI Level 3 certifications, AWS Partner status, and access to multiple federal contract vehicles (GSA MAS, CIO-SP3 SB, NCI CBBIIT PITS BPA, SPARC-SB, FDIC ITAS NG BOA) that anchor its government services revenue.
In April 2026, CTIS launched Trial SafetyXchange, a cloud-based SaaS platform that automates the conversion of Individual Case Safety Report files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard for adverse event reporting. The product is targeted at small and mid-size pharmaceutical companies, biotech firms, and contract research organizations facing the FDA's April 1, 2026 compliance deadline and positioned as a low-cost, immediately deployable alternative to enterprise pharmacovigilance platforms. CTIS combines subscription SaaS revenue from Trial SafetyXchange with managed and professional services revenue from its federal health IT practice, distributed through a sales-led enterprise motion with quote-based engagement and no public pricing.
CTIS firmographics
Firmographics- Name
- CTIS
- Legal name
- CTIS, Inc.
- Website
- https://ctisinc.com
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- CTIS is a Rockville, Maryland-based Women-Owned Small Business providing health IT services to federal healthcare agencies and academic medical centers, and in April 2026 launched Trial SafetyXchange, a SaaS platform that automates FDA E2B(R3) adverse event reporting compliance for pharma, biotech, and CRO customers.
- Ownership category
- akta.pro rank
CTIS industry classification
Industry- Product category
- Health IT Services
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Safety/Pharmacovigilance (PV) & Clinical Safety Systems (HLACAOAH)
- akta.pro secondary industries
- Clinical Trial Management Systems (CTMS) (HLACAOAD), Safety Database Operations & Hosting (Argus/ARISg/Oracle) (HLAGALAB)
Keywords
Where CTIS is headquartered
LocationHeadquarters
- HQ city
- Rockville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
CTIS business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- SaaS Subscription (Trial SafetyXchange): Cloud-based SaaS subscription model for the Trial SafetyXchange platform. Offers immediate deployment as an affordable alternative to traditional enterprise compliance platforms for FDA E2B(R3) compliance.
- Health IT Services: End-to-end solutions including Data Services, Health Information Solutions, IT Modernization, AI/ML Enablement, IT Infrastructure & Security, and DevSecOps delivered as professional services and managed services.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
CTIS product offering
Product offeringCore offering
CTIS is a Health IT and clinical research informatics company that delivers end-to-end solutions spanning Data Services, Health Information Solutions, IT Modernization, AI/ML Enablement, IT Infrastructure & Security, and DevSecOps. Its flagship product, Trial SafetyXchange, is a cloud-based SaaS platform that automates the conversion of Individual Case Safety Report (ICSR) files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard for adverse event reporting compliance ahead of the April 1, 2026 deadline.
Product overview
CTIS offers a portfolio of Health IT and clinical research informatics solutions. The primary product is Trial SafetyXchange, a cloud-based SaaS platform designed for FDA compliance in clinical trials. The company also provides end-to-end solutions including Data Services, Health Information Solutions, IT Modernization, and AI/ML Enablement capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- Trial SafetyXchange: Cloud-based SaaS solution that automates the conversion of Individual Case Safety Report files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard for adverse event reporting compliance.
Products and services
- Trial SafetyXchange A cloud-based SaaS solution that automates the conversion of Individual Case Safety Report (ICSR) files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard, helping pharmaceutical companies, biotech firms, and CROs meet the April 1, 2026 compliance deadline for adverse event reporting in clinical trials.
- Health IT End-to-End Solutions
Quantifiable outcome
- Addresses FDA April 1, 2026 compliance deadline for adverse event reporting
Companies that use CTIS
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
CTIS technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
CTIS partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and flagship.
- AWS (Amazon Web Services)coreCTIS holds AWS Partner status, indicating cloud infrastructure and technology integration partnership for delivering SaaS solutions.
- U.S. Federal GovernmentflagshipCTIS holds multiple government contract vehicles including GSA Multiple Award Schedule, CIO-SP3 SB, NCI CBBIIT PITS BPA, SPARC-SB, and FDIC ITAS NG BOA, enabling direct procurement by federal agencies including NIH, FDA, VA, and CMS.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
CTIS competitors and assessment
Company assessmentBroad incumbents
- Leidos: Leidos is a large federal health IT contractor serving NIH, FDA, VA, and CMS — directly overlapping CTIS's federal healthcare agency customer base and contract vehicle footprint.
- IQVIA: IQVIA is a global CRO and health IT provider with safety/pharmacovigilance services and technology; it operates across the full clinical trial lifecycle that CTIS targets via its narrower SMB-focused SaaS offering.
- Booz Allen Hamilton: Booz Allen is a major federal health IT and digital modernization contractor, comparable to CTIS's federal health IT services arm across NIH, FDA, VA, and CMS engagements.
Direct peers
- Sparta Systems (TrackWise): TrackWise provides quality and safety management for pharma, including adverse event and case management workflows overlapping with CTIS's Trial SafetyXchange use case.
- Veeva Systems: Veeva's Vault Safety is a leading cloud-based pharmacovigilance platform for adverse event reporting and ICSR management, directly competing with CTIS's Trial SafetyXchange for the same pharma/biotech/CRO buyer.
- ArisGlobal: ArisGlobal's LifeSphere Safety platform provides pharmacovigilance, case management, and E2B submission software, competing head-on with Trial SafetyXchange for pharma safety teams.
- Dassault Systèmes (Medidata): Medidata's clinical trial technology suite includes safety reporting and E2B submission capabilities serving pharma and CROs, an adjacent but comparable offering to CTIS's Trial SafetyXchange.
- Oracle Health Sciences (Argus Safety): Oracle's Argus Safety is the dominant enterprise safety database for ICSR/E2B submissions and adverse event reporting, the primary incumbent CTIS positions Trial SafetyXchange against for SMB and mid-market pharma.
Others
- Parexel International: Parexel is a global CRO that relies on pharmacovigilance and safety reporting technology for its sponsor clients, making it a potential channel partner and indirect buyer profile for Trial SafetyXchange.
Emerging players
- Saama Technologies: Saama provides AI-enabled clinical trial and pharmacovigilance analytics, competing with CTIS in clinical research informatics SaaS for pharma and biotech with overlapping buyer personas.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key highlights7 records
Customer concentration
CTIS social profiles
Digital presenceCTIS compliance and trust
Trust signalCompliance4 records
CTIS financial estimates
Financial estimateRevenue estimate
Valuation estimate
CTIS leadership team
Management profileNumber of profiles
CTIS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CTIS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CTIS
What does CTIS do?
CTIS is a Health IT and clinical research informatics company that delivers end-to-end solutions spanning Data Services, Health Information Solutions, IT Modernization, AI/ML Enablement, IT Infrastructure & Security, and DevSecOps. Its flagship product, Trial SafetyXchange, is a cloud-based SaaS platform that automates the conversion of Individual Case Safety Report (ICSR) files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard for adverse event reporting compliance ahead of the April 1, 2026 deadline.
Is CTIS a public or private company?
CTIS is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was CTIS founded?
CTIS was founded in 1993. It employs 101 to 250 people.
Where is CTIS based?
CTIS is headquartered in Rockville, United States, in the North America region.
How does CTIS make money?
Two revenue lines are on record. SaaS Subscription (Trial SafetyXchange) is the primary driver. The others are health IT Services.
Who are CTIS's main competitors?
Broad incumbents on record are Leidos, IQVIA and Booz Allen Hamilton. Direct peers are Sparta Systems (TrackWise), Veeva Systems, ArisGlobal, Dassault Systèmes (Medidata) and Oracle Health Sciences (Argus Safety). Parexel International is listed as an others. Saama Technologies is listed as an emerging player.
Does CTIS have an API?
No public API is recorded for CTIS.
What industry is CTIS in?
CTIS's product category is Health IT Services. Its primary akta.pro industry code is HLACAOAH, Safety/Pharmacovigilance (PV) & Clinical Safety Systems, with a secondary code of HLACAOAD, Clinical Trial Management Systems (CTMS). Its NAICS code is 54151 and its SIC code is 7372.